Concepedia

Author

A. M. Patiño-Trives

Instituto Maimónides de Investigación Biomédica de CórdobaORCID

Also Known As

A. M. Patiño-Trives, A.M. Patiño-Trives, Alejandra M. Patiño-Trives, Alejandra M. Patiño‐Trives, Alejandra Maria Patiño-Trives, Alejandra Maria Patiño‐Trives, Alejandra María Patiño-Trives, Alejandra Patiño-Trives

37

Publications

337

Citations

11

H-Index

13

Concepts

All Affiliations

Instituto Maimónides de Investigación Biomédica de CórdobaUniversity of CórdobaInstituto de Salud Carlos IIIHospital Universitario Reina SofíaInstitute for Research in Biomedicine
AM

About

A. M. Patiño-Trives is an author at Instituto Maimónides de Investigación Biomédica de Córdoba specializing in allergy, inflammation, and chronic inflammation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

33

2

Allergy

1

1

33

3

Immunology

1

1

33

4

Pathology

1

1

33

5

Rheumatology

1

1

33

A. M. Patiño-Trives

×

10

Publications

282

Citations

10

H-Index

YearCitations

Anti-dsDNA Antibodies Increase the Cardiovascular Risk in Systemic Lupus Erythematosus Promoting a Distinctive Immune and Vascular Activation

A. M. Patiño-Trives, C. Pérez‐Sánchez, Laura Pérez‐Sánchez,

Arteriosclerosis Thrombosis and Vascular Biology

2021

55

Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy

Alejandro Ibáñez‐Costa, C. Pérez‐Sánchez, A. M. Patiño-Trives,

Annals of the Rheumatic Diseases

2021

46

Impaired microRNA processing in neutrophils from rheumatoid arthritis patients confers their pathogenic profile. Modulation by biological therapies

I. Arias de la Rosa, C. Pérez‐Sánchez, Patricia Ruiz‐Limón,

Haematologica

2020

33

Molecular Characterization of Monocyte Subsets Reveals Specific and Distinctive Molecular Signatures Associated With Cardiovascular Disease in Rheumatoid Arthritis

Patricia Ruiz‐Limón, R. Ortega Castro, Nuria Barbarroja,

Frontiers in Immunology

2019

27

The clinical and molecular cardiometabolic fingerprint of an exploratory psoriatic arthritis cohort is associated with the disease activity and differentially modulated by methotrexate and apremilast

I. Arias de la Rosa, María Dolores López-Montilla, Cristóbal Román-Rodríguez,

Journal of Internal Medicine

2022

24

Subclinical cardiovascular risk signs in adults with juvenile idiopathic arthritis in sustained remission

I. C. Aranda-Valera, I. Arias de la Rosa, Rosa Roldán‐Molina,

Pediatric Rheumatology

2020

23

Early restoration of immune and vascular phenotypes in systemic lupus erythematosus and rheumatoid arthritis patients after B cell depletion

C. Pérez‐Sánchez, Irene Cecchi, Nuria Barbarroja,

Journal of Cellular and Molecular Medicine

2019

21

Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic Analyses

Laura Pérez‐Sánchez, A. M. Patiño-Trives, M. Á. Aguirre,

Arteriosclerosis Thrombosis and Vascular Biology

2020

21

Complement component 3 as biomarker of disease activity and cardiometabolic risk factor in rheumatoid arthritis and spondyloarthritis

I. Arias de la Rosa, Pilar Font, Alejandro Escudero‐Contreras,

Therapeutic Advances in Chronic Disease

2020

20

Molecular Changes in the Adipose Tissue Induced by Rheumatoid Arthritis: Effects of Disease-Modifying Anti-Rheumatic Drugs

I. Arias de la Rosa, Alejandro Escudero‐Contreras, M. Ruiz-Ponce,

Frontiers in Immunology

2021

12

Page 1